Chemours agreed to a $455 million settlement with North Carolina and local entities over PFAS-related claims. Chemours will bear 50% of settlement payments, while the agreement applies $210 million against the MOU’s $4 billion qualified-spend cap and treats future Escrow contributions as satisfied by settlement payments.
Key Highlights
- The settlement amount is $455 million, payable over 15 years beginning within 30 days of execution.
- Chemours will be responsible for 50% of settlement payments, with DuPont and Corteva responsible for the remaining 50%.
- The settlement will be applied at $210 million against the MOU’s $4 billion qualified-spend cap, and future MOU escrow contributions will be considered satisfied by the North Carolina and New Jersey settlement payments.
Chemours Co (NYSE: CC), DuPont and Corteva (NYSE: CTVA) agreed to a $455 million settlement with North Carolina and local entities over PFAS-related claims. The agreement resolves claims tied to emissions from the Fayetteville Works Facility and certain other PFAS contamination claims involving the state.
$455 Million Settlement Covers PFAS Claims
The settlement was entered on September 9, 2026, and remains subject to orders dismissing the covered claims. Chemours will be responsible for 50% of the settlement payments under the 2021 memorandum of understanding, while DuPont and Corteva will cover the remaining 50%. The agreement also addresses certain obligations under the 2019 Consent Order, including procedures for resolving remaining off-site obligations and implementing drinking water programs.
Settlement Changes MOU Spend and Escrow Treatment
For purposes of the MOU’s $4 billion qualified-spend cap, the settlement is valued at $210 million.
FAQs
Q: What is the Chemours North Carolina PFAS settlement?
A: Chemours agreed to a $455 million settlement with North Carolina and local entities over PFAS-related claims. The payments will be shared among Chemours, DuPont and Corteva.
Q: How does the PFAS settlement affect Chemours’ MOU obligations?
A: Chemours remains responsible for 50% of settlement payments. The settlement also counts as $210 million against the MOU’s $4 billion qualified-spend cap.
Q: What happens to Chemours’ future escrow contributions?
A: Future MOU escrow contributions will be treated as satisfied by settlement payments tied to the North Carolina and 2025 New Jersey agreements. That includes Chemours’ $50 million contribution due in September 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.